ArticleFrontiers in medicine2025
UPLC/Q-TOF MS-based femoral muscle metabolomic analysis under high-temperature: a proof of concept for postmortem interval estimation.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Accurate postmortem interval (PMI) estimation is a major challenge in forensic medicine, especially for the rapidly and highly putrefied bodies in tropical high-temperature areas. Despite numerous studies, there are still no reliable, objective methods to accurately estimate PMI for corpses found in a high-temperature environment. Methods: In the current research, an ultra-high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC/Q-TOF MS)-based metabolomics approach was employed for the analysis of the metabolic profile of rat femoral muscle tissue in a high-temperature environment at different postmortem intervals. Multivariate pattern recognition and pathway analyses were employed for the identification of differential metabolites. Results: This study identified 14 significantly changed metabolites and two altered metabolic pathways. Among them, L-threonine, histidyl-threonine, L-tryptophan, N6-acetyl- L-lysine, eicosapentaenoic acid, glycerol 3-phosphate, and creatine were selected as possible diagnostic biomarkers for PMI estimation. Their impact value and potential biological function in the organisation's degradation process were the basis for selection. Discussion: This study demonstrated the feasibility of UPLC/Q-TOF MS-based metabolomics in femoral muscle tissue research and identified several differential metabolites that may provide forensic scientists with a helpful reference in PMI estimation in a high-temperature environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.